FDA Posts Guidance on Safety Labeling for Drugs and Biologics

The Food and Drug Administration issued a draft guidance on container and carton labeling for prescription drugs and biological products. The draft guidance focuses on how to design container labels and carton labeling in ways that minimize medication errors. Comments on the draft guidance are due by June 24.